Literature DB >> 26470615

Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.

Raed Alhusayen1, Neil H Shear2.   

Abstract

Traditional systemic therapies are frequently prescribed for the treatment of hidradenitis suppurativa (HS). Clinicians consider antibiotics, retinoids, antiandrogens, immunosuppressants, and less common treatment, such as fumarates, in the management of HS. Different classes of medications have been selected to treat HS based on their ability to target various pathways of the condition. Concerns about infection, such as infection with Clostridium difficile, necessitates switching therapy or shortening the course of therapy with specific antibiotics. This review explores the outcomes with the use of numerous medical therapies and postulates explanations for their efficacy or lack of response. Data on long-term safety and efficacy with traditional systemic therapies are lacking.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antiandrogens; antibacterials; evidence-based medicine; fumarates; hidradenitis suppurativa; immunosuppressants; retinoids; zinc

Mesh:

Substances:

Year:  2015        PMID: 26470615     DOI: 10.1016/j.jaad.2015.07.049

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

2.  Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015.

Authors:  Tatiana Cristina Pedro Cordeiro de Andrade; Bruna Cortinóvis Vieira; Agnes Mayumi Nakano Oliveira; Tábata Yamasaki Martins; Tatiane Meira Santiago; Antônio Carlos Ceribelli Martelli
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

3.  The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.

Authors:  A R J V Vossen; C B Ardon; H H van der Zee; E Lubberts; E P Prens
Journal:  Br J Dermatol       Date:  2019-04-12       Impact factor: 9.302

Review 4.  Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review.

Authors:  Sadaf Mohammadi; Abbas Gholami; Lina Hejrati; Masoomeh Rohani; Raheleh Rafiei-Sefiddashti; Alireza Hejrati
Journal:  J Family Med Prim Care       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.